Evidence map›Paper›PMID 31391779›Full record

ArticleBioinformatics and biology insights2019

Homology Modelling and Molecular Docking Studies of Selected Substituted Benzo[

Gbolahan O Oduselu, Olayinka O Ajani, Yvonne U Ajamma, Benedikt Brors, Ezekiel Adebiyi

Open access · goldAbstract read
In one paragraph

Article in Bioinformatics and biology insights, 2019. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 35 papers.

0numbers the graph read from it
0cells of the map it votes in
35citing papers in PubMed
4.6field-weighted citation impact, top 5% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

35 citing papers in PubMed, 78 citations in OpenAlex.

  1. Article
  2. Article
  3. Review
  4. Article
  5. Article
  6. Article
  7. Article
  8. Synthesis,RSC medicinal chemistry · 2025
    Article
  9. Article
  10. Article
  11. Article
  12. Article
  13. Article
  14. Article
  15. Article
  16. Article
  17. Article
  18. Article
  19. Frontiers in bioinformatics · 2024
    Article
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

5 authors at 2 institutions in 2 countries.

Gbolahan O OduseluCovenant University Bioinformatics Research (CUBRe), Covenant University, Ota, Nigeria.
Olayinka O AjaniCovenant University Bioinformatics Research (CUBRe), Covenant University, Ota, Nigeria.ORCID https://orcid.org/0000-0002-3422-3478
Yvonne U AjammaCovenant University Bioinformatics Research (CUBRe), Covenant University, Ota, Nigeria.
Benedikt BrorsDivision of Applied Bioinformatics, German Cancer Research Center (DKFZ), Heidelberg, Germany.
Ezekiel AdebiyiCovenant University Bioinformatics Research (CUBRe), Covenant University, Ota, Nigeria.ORCID https://orcid.org/0000-0002-1390-2359
Covenant University · NGGerman Cancer Research Center · DE

Funding

WEST AFRICAN SUSTAINABLE LEADERSHIP AND INNOVATION TRAINING IN BIOINFORMATICS RESEARCH (WASLITBRe)U2RTW010679 · FIC · COVENANT UNIVERSITY · PI ADEBIYI, EZEKIEL FEMI, AMOAKO-YIRENKYI, PETER · 2017 to 2021
$1.4M
West African Center of Excellence for Global Health Bioinformatics Research TrainingU2RTW010673 · FIC · UNIV OF SCIENCES, TECH & TECH OF BAMAKO · PI DOUMBIA, SEYDOU, LI, JIAN · 2017 to 2021
$1.2M
FIC NIH HHS U2R TW010673FIC NIH HHS U2R TW010679
6 · The paper itself

Abstract

PubMed holds no abstract for this paper.

Indexed as

ADMET predictionantimalarial activitybenzimidamidebenzimidazoledrug targetin silicomalariamolecular docking

Identifiers

PMID31391779
PMCPMC6669854
OpenAlexW2964783067

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.